S&P 500 7,323.63 −0.23%
Nasdaq 24,429.89 +0.42%
S&P/TSX 34,578.05 −2.09%
Apple 352.45 +0.15%
Nvidia 150.96 −2.89%
Microsoft 508.29 +0.40%
Shopify 199.78 −1.50%
Royal Bank 272.26 −3.11%
CAD/USD 0.6994 +0.01%
PRE-MKT · 05:45 ET
Market ClerkRecap
Thu Nov 19 · pre-market7 signals on Nov 18520 insider buys this week · $248.1MCIRO short report next: Nov 30The week ahead
SN
INSIDER · ANRO · Alto Neuroscience, Inc. · PRESIDENT AND CFO

Smith Nicholas Conrad

Every open-market transaction filed under this name, Sep 29 to Sep 30.

Filings
3
0 buys · 3 sells
Bought
—
open market, at cost
Sold
$3.6M
includes scheduled sales
Buys since
—
no current price on file

Filings

SEC FORM 4 · OPEN MARKET
TradedTickerCompanyRoleTypeSharesPriceValueSince
Sep 30ANROAlto Neuroscience, Inc.PRESIDENT AND CFOSell886$26.87$24K−3.6%
Sep 30ANROAlto Neuroscience, Inc.PRESIDENT AND CFOSell23,170$25.78$597K+0.5%
Sep 29ANROAlto Neuroscience, Inc.PRESIDENT AND CFOSell110,830$26.58$2.9M−2.5%

"Since" is the stock's move from the filed price to the latest quote on file, not a scored call. Open-market purchases and sales only; option exercises and grants are excluded.